NOTICE OF UPGRADE

Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022

InvestoGain Australia
 

SEARCH LISTED COMPANY


Any AUS or NZ company

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH PRIVATE COMPANY


SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

ECS BOTANICS HOLDINGS LTD (ECS)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

 FROMTO
ECS BOTANICS HOLDINGS LTD16/07/2019
AXXIS TECHNOLOGY GROUP LTD07/01/201516/07/2019
ANITTEL GROUP LIMITED01/12/201007/01/2015
HOSTECH LIMITED04/02/200901/12/2010
MOBI LIMITED30/11/200504/02/2009
FUSIA LIMITED19/04/200430/11/2005
TENNYSON NETWORKS LIMITED31/05/200019/04/2004
TENNYSON HOLDINGS LIMITED09/01/198631/05/2000
TENNYSON HOLDINGS NL01/08/198509/01/1986
TENNYSON MINERALS NL01/08/1985

Shareholder links

Our website ranking of ECS: rating 2
(2 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Automic Group
Level 5, 191 ST GEORGES TERRACE PERTH WA 6000
Tel : +61 (2) 8072 1400 or 1300 288 664 (within Australia)
RegistryWebsite RegistryEmail

Company details

ISIN: AU0000052490
Address: 94 Green Rises Road, Cressy, Tasmania 7302, Australia
Tel:  +61 419 323 059 Fax: 1300 886 783

Date first listed: 13/03/1986

Sector: Pharmaceuticals Biotechnology & Life Sciences Industry Group: XIJ
Activities: Industrial Hemp

News & Events

Expand this box to read and print

The suspension of trading in the securities of ECS will be lifted immediately following the release by ECS of an announcement regarding a supply and tolling agreement with a pharmaceutical company.

23/11/2021

Sun Pharma will extract medicinal cannabis biomass cultivated by ECS Botanics to produce GMP resin. ECS Botanics will supply Sun Pharma with additional biomass for their commercial requirements. By leveraging the expertise of each company, this long-term collaboration agreement provides both companies with a strong platform for growth. Agreement provides for future collaboration between Sun Pharma and ECS Botanics.

23/11/2021

The securities of ECS Botanics Holdings Ltd will be suspended from quotation immediately under Listing Rule 17.2, at the request of ECS, pending the release of an announcement regarding a supply and tolling agreement with a pharmaceutical company.

22/11/2021

The suspension of trading in the securities of ECS Botanics Holdings Ltd will be lifted from the commencement of trading on Monday, 22 July 2019, following ECS's re-compliance with Chapters 1 and 2 of the Listing Rules.

19/07/2019

The suspension of trading in the securities of ECS Botanics Holdings Ltd is expected to lift and the company reinstated to official quotation at the commencement of trading on Monday 22 July 2019 at 10am AEST, following its re-compliance with Chapters 1 and 2 of the ASX Listing Rules. The company raised $6,500,000 pursuant to the offer under its replacement prospectus dated 10 May 2019 by the issue of 162,500,000 shares at an issue price of $0.04 per share.

19/07/2019

name changed from Axxis Technology Group Ltd

16/07/2019

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.
Loading comments....  Most recent comments

CHANGE OF SHARE REGISTRY TO Automic 

18/09/2023 22:39:27

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    15/06/2023Nan-Maree Schoerie400,000$0.020$8,000
    09/06/2023Nan-Maree Schoerie300,020$0.020$6,000
    05/06/2023Nan-Maree Schoerie299,980$0.019$5,692
    07/11/2022Jeremy King1,250,000$0.023$28,750
    20/06/2022Nan-Maree Schoerie5,000,000$0.018$89,776

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Jason HineCOO11/07/2019
    Jeremy KingNon Exec Director11/01/2017
    Michael NitscheNon Exec Director25/03/2019
    Nan-Maree SchoerieNon Exec Director14/01/2021
    Mauro PicciniCompany Secretary

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Alex KeachExecutive Director11/07/201906/05/2024
    David McCredieNon Exec Director11/07/201915/06/2022
    Justyn StedwellNon Exec Director31/03/201611/07/2019
    Eddie KingDirector11/01/201725/03/2019
    Peter KazacosChairman, Managing Director30/04/201013/01/2017
    Campbell CorfeNon Exec Director02/06/200931/03/2016
    Chris CalamosFinance Director06/06/201111/01/2016
    John WaltersIndependent Director18/07/201103/01/2015
    Michael O'SullivanExecutive Director, COO21/03/201103/01/2015
    Carlos PerezManaging Director, CEO13/01/201021/07/2011
    Ilkka TalesDirector, CEO11/11/200921/07/2011
    Alan ChalmersDirector29/06/200929/01/2011
    Matthew CostelloNon Exec Director02/06/200927/11/2010
    Steve McAllisterNon Exec Director30/04/201027/11/2010
    Terry CookeNon Exec Chairman18/06/200802/12/2009
    Michael Abela14/12/200730/10/2009
    Vince LeoneNon Exec Director02/07/200704/06/2009
    Damian WoodsNon Exec Director04/06/2009
    Nicholas Pike25/05/200721/06/2008
    Fabio PannutiChairman06/10/200613/02/2008
    Garry ShollCEO05/06/200619/12/2007
    Karl MorrisManaging Director31/07/200627/05/2007
    George KarantziasNon Exec Director30/01/200728/02/2007
    Daren AndersonNon Exec Director27/01/200622/11/2006
    Richard CareyManaging Director15/12/200416/11/2006
    Graham HoskingNon Exec Director05/06/200602/08/2006
    Kevin BroughNon Exec Director17/03/200507/06/2006
    Bruce IndNon Exec Director27/01/200607/06/2006
    Russell ScrimshawChairman15/12/200429/01/2006
    Ramin MarzbaniNon Exec Director15/12/200430/11/2005
    David SteinepreisChairman24/12/200317/12/2004
    Gary SteinepreisNon Exec Director24/12/200317/12/2004
    Ross LeightonNon Exec Director06/08/200107/01/2004
    Geoffrey RubythonNon Exec Director16/07/200326/12/2003
    John W. FletcherNon Exec Director16/07/200326/12/2003
    Edward BarryNon Exec Director06/08/200116/11/2003
    Hugh WarnerNon Exec Chairman24/12/200309/11/2003
    Harvey ParkerManaging Director06/08/200109/11/2003
    Ronald WossNon Exec Director23/12/198619/07/2003
    Leigh ColemanCEO15/10/200126/09/2002

    Date of first appointment, title may have changed.